OncLive recently reported on a presentation made by Lymphoma Program Director, Dr. John Leonard at the 2016 International Congress on Hematologic Malignancies on novel treatments that could improve the long term survival of patients with follicular lymphoma. In introducing this topic he noted,
“Most patients will not die from follicular lymphoma, and that’s very reassuring. About 80% of patients will die with their follicular lymphoma and not of their follicular lymphoma…That really tells you something. If 80% of patients are not going to die from their disease, we can make a patient feel a lot better and can guide how we treat the patient.”
The article than summarizes Dr. Leonard’s discussion of these potential new treatments. Some of these treatments for follicular lymphoma are currently being investigated in clinical trials at Weill Cornell Medicine. If you are interested in a trial for follicular lymphoma, please look to our Joint Clinical Trials listings.